205 related articles for article (PubMed ID: 19101800)
1. Sildenafil, an inhibitor of phosphodiesterase subtype 5, prevents indomethacin-induced small-intestinal ulceration in rats via a NO/cGMP-dependent mechanism.
Kato N; Mashita Y; Kato S; Mitsufuji S; Yoshikawa T; Takeuchi K
Dig Dis Sci; 2009 Nov; 54(11):2346-56. PubMed ID: 19101800
[TBL] [Abstract][Full Text] [Related]
2. Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats.
Tanaka A; Mizoguchi H; Kunikata T; Miyazawa T; Takeuchi K
J Physiol Paris; 2001; 95(1-6):35-41. PubMed ID: 11595416
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
Kamei K; Kubo Y; Kato N; Hatazawa R; Amagase K; Takeuchi K
Dig Dis Sci; 2008 Oct; 53(10):2657-66. PubMed ID: 18306037
[TBL] [Abstract][Full Text] [Related]
4. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
Takeuchi K; Yokota A; Tanaka A; Takahira Y
Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
[TBL] [Abstract][Full Text] [Related]
5. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
[TBL] [Abstract][Full Text] [Related]
6. Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
Kubo Y; Kumano A; Kamei K; Amagase K; Abe N; Takeuchi K
Dig Dis Sci; 2010 Jun; 55(6):1570-80. PubMed ID: 19707872
[TBL] [Abstract][Full Text] [Related]
7. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
Takeuchi K; Miyazawa T; Tanaka A; Kato S; Kunikata T
Digestion; 2002; 66(1):30-41. PubMed ID: 12379813
[TBL] [Abstract][Full Text] [Related]
9. Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats.
Medeiros JV; Gadelha GG; Lima SJ; Garcia JA; Soares PM; Santos AA; Brito GA; Ribeiro RA; Souza MH
Br J Pharmacol; 2008 Feb; 153(4):721-7. PubMed ID: 18071300
[TBL] [Abstract][Full Text] [Related]
10. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
[TBL] [Abstract][Full Text] [Related]
11. Cinacalcet, a calcimimetic, prevents nonsteroidal antiinflammatory drug-induced small intestinal damage in rats.
Hayashi S; Kurata N; Kitahirachi E; Nishimura Y; Amagase K; Yano T; Takeuchi K
J Physiol Pharmacol; 2013 Aug; 64(4):453-63. PubMed ID: 24101391
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
[TBL] [Abstract][Full Text] [Related]
13. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.
Kunikata T; Tanaka A; Miyazawa T; Kato S; Takeuchi K
Dig Dis Sci; 2002 Apr; 47(4):894-904. PubMed ID: 11991626
[TBL] [Abstract][Full Text] [Related]
14. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
Hayashi S; Kurata N; Yamaguchi A; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141
[TBL] [Abstract][Full Text] [Related]
15. Influence of Adrenalectomy on Protective Effects of Urocortin I, a Corticotropin-Releasing Factor, Against Indomethacin-Induced Enteropathy in Rats.
Takeuchi K; Abe N; Kumano A
Curr Neuropharmacol; 2016; 14(8):866-875. PubMed ID: 27397599
[TBL] [Abstract][Full Text] [Related]
16. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Kato S; Tanaka A; Kunikata T; Korolkiewicz R; Takeuchi K
Pharmacol Res; 1999 Dec; 40(6):517-24. PubMed ID: 10660951
[TBL] [Abstract][Full Text] [Related]
17. Lack of small intestinal ulcerogenecity of nitric oxide-releasing indomethacin, NCX-530, in rats.
Mizoguchi H; Hase S; Tanaka A; Takeuchi K
Aliment Pharmacol Ther; 2001 Feb; 15(2):257-67. PubMed ID: 11148446
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of Magnesium Ion Prevents Indomethacin-Induced Intestinal Ulcerogenic Lesions in Adjuvant-Induced Arthritis Rats.
Nagai N; Ueno A; Tanino T; Oka M; Ito Y
Biol Pharm Bull; 2017; 40(6):910-915. PubMed ID: 28566633
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
